Stock NUVB NUVATION BIO INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Nuvation Bio Inc.

Equities

NUVB

US67080N1019

Market Closed - Nyse
Other stock markets
 01:30:02 27/04/2024 am IST 		5-day change 1st Jan Change
2.68 USD +2.29% Intraday chart for Nuvation Bio Inc. +3.08% +77.48%
17/04 RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk MT
10/04 Nuvation Bio Closes Acquisition of AnHeart Therapeutics MT

Chart calendar Nuvation Bio Inc.

b2b91a5a313d8.rG9b1SW2j5ZtD8tkxtjM3sNOh-X5cNRpEtztLP1dOoQ._VYMonPv36QJf5o0gKyOnZB2wY-BHp0cdPHfWKoyDcnoXjWHV-DpxQtQpA~af35e9c1d0b84703112265325e0339ec

Upcoming events on Nuvation Bio Inc.

13/05/2024 Q1 2024 Earnings Release (Projected)
02/06/2024 03:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: 8520
01/08/2024 Q2 2024 Earnings Release (Projected)
31/10/2024 Q3 2024 Earnings Release (Projected)
26/02/2025 Q4 2024 Earnings Release (Projected)

Past events on Nuvation Bio Inc.

01/03/2024 02:31 am Q4 2023 Earnings Release
03/11/2023 01:40 am Q3 2023 Earnings Release
04/08/2023 01:40 am Q2 2023 Earnings Release
15/05/2023 08:30 pm Annual General Meeting
05/05/2023 01:35 am Q1 2023 Earnings Release
16/03/2023 01:35 am Q4 2022 Earnings Release
04/11/2022 01:35 am Q3 2022 Earnings Release
05/08/2022 01:35 am Interim 2022 Earnings Release
16/05/2022 07:30 pm Annual General Meeting
10/05/2022 01:35 am Q1 2022 Earnings Release
01/03/2022 02:35 am FY 2021 Earnings Release
11/01/2022 06:00 pm JP Morgan Healthcare Conference
11/11/2021 02:35 am Q3 2021 Earnings Release
13/08/2021 01:35 am Interim 2021 Earnings Release
10/08/2021 Wedbush Pacgrow Healthcare Conference
02/06/2021 06:30 pm Jefferies Healthcare Conference
18/05/2021 02:30 am Q1 2021 Earnings Release
12/03/2021 03:45 am FY 2020 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-32,1


-43,6
-40,1
-8.56%		-93,3
-90,1
-3.57%		-120
-123
2.27%		-99,8
-107
6.41%
-125

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-41,7
-38,2
-9.15%		-86,8
-87,0
0.18%		-104
-108
3.31%		-75,8
-84,8
10.62%
-101

Net income
Million USD		Released
Forecast
Spread 		0,00


-64,3
-38,2
-68.43%		-86,8
-87,0
0.18%		-104
-108
3.31%		-75,8
-84,8
10.62%
-101

EPS
USD		Released
Forecast
Spread 		-0,16


-0,23
-0,16
-48.39%		-0,44
-0,43
-1.54%		-0,48
-0,50
3.68%		-0,35
-0,39
9.48%
-0,35

Announcement Date12/11/2011/03/2128/02/2215/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-29,6
-26,4
-12.17%		-28,2
-32,2
12.48%		-37,9
-30,5
-24.09%		-29,3
-32,3
9.19%		-24,3
-27,1
10.23%		-26,5
-24,1
-9.96%		-26,1
-27,6
5.33%		-26,3
-27,4
3.94%		-20,8
-27,7
24.71%
-27,5


-28,8


-33,4


-35,7


-51,1

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-25,1
-25,3
0.62%		-21,3
-30,9
31.03%		-34,9
-28,6
-22.07%		-27,2
-30,5
10.75%		-20,8
-24,8
15.91%		-21,7
-22,1
1.47%		-20,6
-25,5
19.09%		-19,6
-23,8
17.45%		-13,8
-22,8
39.53%
-21,2


-22,6


-27,4


-29,4


-44,0

Net income
Million USD		Released
Forecast
Spread 		-25,1
-25,3
0.62%		-21,3
-30,9
31.03%		-34,9
-28,6
-22.07%		-27,2
-30,5
10.75%		-20,8
-24,8
15.91%		-21,7
-22,1
1.47%		-20,6
-25,5
19.09%		-19,6
-23,8
17.45%		-13,8
-22,8
39.53%
-21,2


-22,6


-27,4


-29,4


-44,0

EPS
USD		Released
Forecast
Spread 		-0,12
-0,12
-1.41%		-0,10
-0,14
30.56%		-0,16
-0,13
-20%		-0,12
-0,14
14.29%		-0,10
-0,12
13.04%		-0,10
-0,10
0%		-0,09
-0,11
19.41%		-0,09
-0,11
18.18%		-0,06
-0,11
42.86%
-0,10


-0,08


-0,09


-0,10


-0,11

Announcement Date28/02/2209/05/2204/08/2203/11/2215/03/2304/05/2303/08/2302/11/2329/02/24-----

Upcoming sector events for Nuvation Bio Inc.

29/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
29/04/2024 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
29/04/2024 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
29/04/2024 MORPHOSYS AG: Q1 2024 Earnings Release
30/04/2024 01:35 am QIAGEN N.V.: Q1 2024 Earnings Release
30/04/2024 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
01/05/2024 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Nuvation Bio Inc.

Today GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
Today GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 10:30 am BB BIOTECH AG: Q1 2024 Earnings Release
26/04/2024 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
26/04/2024 HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
26/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 04:30 pm MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
25/04/2024 11:30 am PURETECH HEALTH PLC: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NUVB Stock
  4. Calendar Nuvation Bio Inc.